Margaret is a Chief Investigator of the EC Partnership. She is the Deputy Director of Programs at the Burnet Institute. For almost two decades Margaret’s work has centred around infectious diseases, preventing their transmission and identifying the impact of these infections in vulnerable populations. A researcher and clinician, her principal research interests are in the epidemiology of blood-borne viruses (BBVs) HIV, hepatitis B and hepatitis C, sexually transmitted infections, and improving the management of individuals who already have the infection.
Dr Alisa Pedrana is recognised as one of Australia’s emerging public health researchers, with a significant track record in HIV and sexual health research and epidemiology, and the application of information communication technology for health promotion. Her research interests focus on undertaking innovative epidemiological and public health research, and blood-borne virus epidemiology and health promotion with particular interests in mHealth and exploring how to adapt and apply new technologies for health communication and health system strengthening.
Jacqui Richmond commenced working as a hepatology nurse in 1998 at St. Vincent’s Hospital, Melbourne. She completed a MPH (Deakin University) in 2000 and a PhD in 2006 at the University of Melbourne. Jacqui undertook postdoctoral research at Duke University, Durham, North Carolina in 2007-2008. Jacqui was awarded a National Health and Medical Research Council (NHMRC) Translation of Research into Practice (TRIP) Fellowship, commencing in 2015; based between La Trobe University and Melbourne Health. The project aims to address the gap between optimal and current management of chronic hepatitis B through the development and implementation of a nurse-led model of care in a high hepatitis B prevalence area of Melbourne. This service will complement existing services, build capacity in the sector, and specifically target the need for improved screening, follow up and management of this vulnerable group of patients.
Joseph is a physician and researcher with a particular interest in the epidemiology, management and prevention of blood borne viruses (HIV, hepatitis C and hepatitis B). With a background in clinical medicine, Joseph specialised in infectious diseases at the Alfred where he works as a consultant physician. He completed his MPH at the London School of Hygiene and Tropical Medicine and his public health fellowship was undertaken at the Victorian Infectious Diseases Reference Laboratory and Burnet Institute. His PhD at Burnet and Monash School of Population Health was focused on the effectiveness of early hepatitis C treatment.
Judy Gold has over 10 years’ experience in research, public health and international development. Her PhD involved developing and evaluating new approaches for sexual health promotion to young people using SMS and social networking sites. After completing her PhD, Judy moved to London where she worked for several international NGOs focused on sexual and reproductive health and rights, and as a freelance consultant. Judy returned to the Burnet Institute in May 2016, where she is currently working part time to coordinate health promotion activities to increase the number of people who inject drugs accessing Hepatitis C treatment.
Associate Professor Stoové has researched the transmission and impact of sexually transmitted infections and blood borne viruses among key risk populations, primarily people who inject drugs and men who have sex with men, for more than 12 years. His research interests focus on undertaking innovative epidemiological and public health research and disease surveillance, with particular interests in prospective observational studies and the application of record linkage and bio-behavioural data collection to these study designs.
Peter has a background in community development and has worked with marginalised populations for over 20 years in Melbourne, Sydney, Vietnam, Indonesia and China. His field based research has been focused on risk and people who inject drugs. Peter is teaching undergraduate and postgraduate students in Public Health at La Trobe University. He maintains involvement in various studies of cohorts of injecting drug users in Melbourne.
Paul is one of Australia’s leading alcohol and other drug epidemiologists with a significant national, and emerging international profile. He is an NHMRC Senior Research Fellow and a past ARC Future Fellow and VicHealth Public Health Research Fellow. With more than 20 years’ experience and an outstanding track record, his work has established internationally innovative surveillance systems and applied research designs that break new ground in the public health research into alcohol and other drug use and related harms in Australia.
Alex is the Director of the Department of Gastroenterology at St Vincent’s Hospital, Melbourne. He is a NHMRC Research Fellow of the University of Melbourne (St. Vincent’s Hospital, Melbourne), Senior Research Fellow at the Victorian Infectious Diseases Reference Laboratory (VIDRL) and an Adjunct Assistant Professor of the Department of Gastroenterology, Duke University Medical Centre. Prof. Thompson was involved in the discovery of IL28B polymorphism as a predictor of treatment outcome in HCV. His major research interest is the identification of host and viral determinants of the natural history and treatment outcomes of hepatitis B and C viruses.
Lisa has many years of nursing experience in various hospital and community roles. Over the past decade she has worked as a community health nurse, specifically within the areas of homelessness and Alcohol and Other Drugs (AOD). Lisa has a special interest in working with people that are marginalised or disadvantaged, with a focus on health equity, social justice and more recently, disease elimination.
Kico completed her Bachelor of Nursing at La Trobe University in 2012. Kico is a registered nurse and has spent a number of years working in the community, including GP clinics, community health centres, NSPs, and 24 hour Supercare pharmacies.
Filip joined Burnet Institute in 2019 on the Disease Elimination and Behaviours and Health Risks programs. He will be conducting research on Eliminating Hepatitis C cohort study as well as policy related to take-home naloxone in Australia.
Bridget is a Research Assistant working on the EC Partnership project. In 2015, Bridget completed her honours project on the acceptability of HIV pre-exposure prophylaxis among gay men and transgender women in Myanmar. In 2016, Bridget started working at the Burnet Institute coordinating an evaluation of HIV and STI health promotion campaigns, an evaluation of rapid HIV testing in Adelaide and working on data management for the Prime Study.
Jack joined the Burnet Institute in 2019 to work on multiple projects in the Eliminate Hepatitis C Partnership Project and Behaviour and Health Risks Program. Jack has interests in both qualitative and quantitative research, AOD harm reduction, mental health, and blood-borne viruses.
Chloe has worked in community health including AOD and harm reduction for most of her nursing career, as well as some time doing clinical hepatology. She’s interested in working with marginalised populations, health equity, and disease elimination.
Tara is a public health registrar working within the Disease Elimination program at the Burnet Institute. Her work will focus on the Eliminate Hepatitis C Partnership.
In 2012 Kathleen began a Masters of Public health at the University of Melbourne, specialising in global health and epidemiology. Kathleen joined the Burnet Institute in 2014, commencing her PhD in the evaluation of Victoria’s first community based, rapid HIV testing service, PRONTO!. She was awarded her PhD in 2018 and currently coordinates the EC Experience study.
Michael joins Burnet as a research assistant for the ACCESS (Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of STIs and BBVs) project. He has a particular interest in STI and blood-borne virus epidemiology among disadvantaged and high-risk populations, including gay and bisexual men, people who inject drugs and young people.
Ms. Anna Wilkinson is an early career public health researcher, with interests in epidemiology, biostatistics, maximising the use of data, and evaluating public health policy. Ms. Wilkinson has an extensive clinical background including working as a research nurse at the Alfred Hospital and Burnet Institute. Previously Anna has worked in diverse clinical settings, including in rural and remote Australia and in the UK. This breadth of clinical work has provided an important foundation for her public health research career.
Melissa is a nurse and public health professional. She currently coordinates the EC Training and Education program.
Michelle is a public health registrar at the Burnet Institute. She commenced Advanced Training with the Australasian Faculty of Public Health Medicine in 2015. Michelle’s work at Burnet is with the Disease Elimination program.